Sarah E. Pinder

41.6k citations

328 papers · 15.0k indexed · h-index 67

Impact in

Cancer Research top 0.05%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Pathology and Forensic Medicine top 0.1%
- Breast Lesions and Carcinomas

Papers in

Cancer Research 205
- Breast Cancer Treatment Studies 183
- Cancer Genomics and Diagnostics 28
Pathology and Forensic Medicine 150
- Breast Lesions and Carcinomas 142

Co-authors: Ian O. Ellis J.F.R. Robertson Carlos Caldas R.W. Blamey Arnie Purushotham Elena Provenzano C.W. Elston Claire E. Paish
Journals: Clinical Radiology (20 papers)Histopathology (18 papers)British Journal of Cancer (17 papers)Journal of Clinical Pathology (16 papers)Cancer Research (14 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Sarah E. Pinder

320 papers receiving 14.6k citations

Peers

Countries citing papers authored by Sarah E. Pinder

Since Specialization

Citations

This map shows the geographic impact of Sarah E. Pinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah E. Pinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah E. Pinder more than expected).

Fields of papers citing papers by Sarah E. Pinder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah E. Pinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah E. Pinder. The network helps show where Sarah E. Pinder may publish in the future.

Co-authors

The 25 scholars most cited alongside Sarah E. Pinder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sarah E. Pinder Line = papers co-authored together Sarah E. Pinder links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Deep learning for predicting invasive recurrence of ductal carcinoma in situ: leveraging histopathology images and clinical features EBioMedicine ·MJ Gaitán, Esther H. Lips, И В Гальцева, Lennart Mulder, 寛加須屋, A. Maketzki, Parnian Ghoraishi, Arianna Kelly, Eline de Jong, Elinor J. Sawyer, Alastair M. Thompson, Sarah E. Pinder, Clara I. Sá‎nchez, Jonas Teuwen, Jelle Wesseling, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2025	1
2	Exploration of utility of combined optical photothermal infrared and Raman imaging for investigating the chemical composition of microcalcifications in breast cancer Analytical Methods ·T. Paganini, Iain Lyburn, Sarah E. Pinder, R.A. Scott, Jessica Mansfield, Julian Moger, Peter Andreadia, Eline de Jong, Eleanor Cornford, Keith D. Rogers, Nicholas Stone	2023	13
3	Integrated Multimodal Analyses of DNA Damage Response and Immune Markers as Predictors of Response in Metastatic Triple-Negative Breast Cancer in the TNT Trial (NCT00532727) Clinical Cancer Research ·Holly Tovey, Flóra Králik, Joel S. Parker, Katherine A. Hoadley, Jelmar Quist, Sarah Kernaghan, Lucy Kilburn, Roberto Salgado, Sherene Loi, Richard D. Kennedy, Ioannis Roxanis, Patrycja Gazińska, Sarah E. Pinder, Judith M. Bliss, Charles M. Perou, Syed Haider, Anita Grigoriadis, Andrew Tutt, Maggie C.U. Cheang	2023	3
4	Unresected screen-detected ductal carcinoma in situ: Outcomes of 311 women in the Forget-Me-Not 2 study The Breast ·Anthony Maxwell, Bridget Hilton, Karen Clements, David Dodwell, 王明千, Olive Kearins, Cliona Kirwan, Janet Litherland, Senthurun Mylvaganam, Elena Provenzano, Sarah E. Pinder, Elinor J. Sawyer, Abeer M. Shaaban, Nisha Sharma, Hilary Stobart, Matthew Wallis, Alastair M. Thompson	2022	21
5	Impact of COVID-19 on the practice of breast pathologists: a survey of breast pathologists in the UK and Ireland Journal of Clinical Pathology ·عزت الله عسکری اصلی زاده, Ahran Khan, 郭扬, Frederik Gejl-Hansen, Elena Provenzano, Rahul Deb, Susan Pritchard, Silvana Di Palma, Ian O. Ellis, Larissa Bini, Sarah E. Pinder, Abeer M. Shaaban	2021	3
6	Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression Science Advances ·James W. Opzoomer, Joanne E. Anstee, Isaac Dean, M.H. Do, Eline de Jong, Jonathan Caron, Tamara Muliaditan, Peter M. Gordon, 雅子浅見, Rosamond Nuamah, Sarah E. Pinder, Tony Ng, Francesco Dazzi, Shahram Kordasti, David R. Withers, Toby Lawrence, James N. Arnold	2021	56
7	Prognostic and Predictive Value of HER2 Expression in Ductal Carcinoma In Situ : Results from the UK/ANZ DCIS Randomized Trial Clinical Cancer Research ·Mangesh A. Thorat, Christopher D. Harlow, J. Louise Jones, Sarah E. Pinder, Nigel Bundred, Ian S. Fentiman, Jack Cuzick	2021	27
8	Prognostic Value of ER and PgR Expression and the Impact of Multi-clonal Expression for Recurrence in Ductal Carcinoma in situ : Results from the UK/ANZ DCIS Trial Clinical Cancer Research ·Mangesh A. Thorat, Christopher D. Harlow, J. Louise Jones, Sarah E. Pinder, Nigel Bundred, Ian S. Fentiman, Jack Cuzick	2021	10
9	Metaplastic carcinomas of the breast without evidence of epithelial differentiation: a diagnostic approach for management Histopathology ·Emad A. Rakha, Cecily Quinn, Maria Pia Foschini, Fabiana Plican Ciena, David J. Dabbs, Sunil R. Lakhani, Zsuzsanna Varga, Sarah E. Pinder, Fernando Schmitt, Jorge S. Reis‐Filho, Stephen B. Fox, Ian O. Ellis, Puay‐Hoon Tan, Digvijay Choudhary	2020	14
10	Cancer-associated hypersialylated MUC1 drives the differentiation of human monocytes into macrophages with a pathogenic phenotype Communications Biology ·Richard Beatson, Rosalind Graham, Helen Grut, Domenico Cozzetto, Shichina Kannambath, Thiago Occhi, Natalie Woodman, Julie Owen, Rosamond Nuamah, Ulla Mandel, Sarah E. Pinder, Cheryl Gillett, Thomas Noll, Eline de Jong, Joyce Taylor‐Papadimitriou, Joy Burchell	2020	50
11	Diagnostic concordance of reporting lymphovascular invasion in breast cancer Journal of Clinical Pathology ·Emad A. Rakha, pWon Bae Jeon Myoung Hee Jeon, Joschko, Maysa E. El‐Sayed, D. Colman, Sarah E. Pinder, Ian O. Ellis	2018	18
12	Histological scoring of immune and stromal features in breast and axillary lymph nodes is prognostic for distant metastasis in lymph node‐positive breast cancers The Journal of Pathology Clinical Research ·Anita Grigoriadis, Patrycja Gazińska, Trupti Pai, Azucena Rodríguez Márquez, Yin Wu, Rosemary R. Millis, Kuban D. Naidoo, Julie Owen, Cheryl Gillett, Andrew Tutt, A C C Coolen, Sarah E. Pinder	2018	20
13	Gene expression modules in primary breast cancers as risk factors for organotropic patterns of first metastatic spread: a case control study Breast Cancer Research ·Katherine Lawler, Efterpi Papouli, Cristina Naceur‐Lombardelli, Anca Mera, David Granderson, Andrew Tutt, Siker Kimbung, Ingrid Hedenfalk, Jun Zhan, Hongquan Zhang, Richard Buus, Mitch Dowsett, Tony Ng, Sarah E. Pinder, Peter J. Parker, Lars Holmberg, Cheryl Gillett, Anita Grigoriadis, Arnie Purushotham	2017	4
14	Nottingham Clinico-Pathological Response Index (NPRI) after Neoadjuvant Chemotherapy (Neo-ACT) Accurately Predicts Clinical Outcome in Locally Advanced Breast Cancer Clinical Cancer Research ·Tarek M. Abdel-Fatah, Graham Ball, Andrew H.S. Lee, Sarah E. Pinder, Samara Fortunato Cardoso, Eleanor Cornford, Paul M. Moseley, Hyung-Ju Na, 长春长春师范大学吉林, Richard A. Nida, D. M. Palmer, Arlene Chan, Ian O. Ellis, Stephen Chan	2014	14
15	Lymphatic mapping and sentinel lymph node biopsy in an in-vivo porcine model using a novel magnetic technique European Journal of Cancer ·Bauke Anninga, Munir Ahmed, Luna Morales, Raluca M. Fratila, B. ten Haken, 王和平, Sarah E. Pinder, Michael Douek	2013	1
16	Comparison of basal-like triple-negative breast cancer defined by morphology, immunohistochemistry and transcriptional profiles Modern Pathology ·Patrycja Gazińska, Anita Grigoriadis, John P. Brown, Rosemary R. Millis, Anca Mera, Cheryl Gillett, Lars Holmberg, Andrew Tutt, Sarah E. Pinder	2013	67
17	Selectin Ligand Sialyl-Lewis x Antigen Drives Metastasis of Hormone-Dependent Breast Cancers Cancer Research ·Sylvain Julien, Aleksandar Ívetic, Anita Grigoriadis, Prof. Dr. Mohammed Ali ALWAN, Brian Burford, Daisy Sproviero, Gianfranco Picco, Cheryl Gillett, Suzanne L. Papp, Lana Schaffer, Andrew Tutt, Joyce Taylor‐Papadimitriou, Sarah E. Pinder, Joy Burchell	2011	156
18	Columnar Cell Lesions of the Breast: The Missing Link in Breast Cancer Progression? The American Journal of Surgical Pathology ·Peter T. Simpson, M. Chaouchel, Jorge S. Reis‐Filho, Chris Jones, Suzanne Parry, J P Sloane, Andrew M. Hanby, Sarah E. Pinder, Andrew H.S. Lee, Iffat Mir, Ian O. Ellis, Sunil R. Lakhani	2005	200
19	False-negative Breast Screening Assessment. What Lessons Can We Learn? Clinical Radiology ·H.C. Burrell, Andrew Evans, A.R.M. Wilson, Sarah E. Pinder	2001	52
20	Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: A comparative study with long follow-up Human Pathology ·Sunil Badve, Roger A’Hern, Rūta Anusevičienė, Rosemary R. Millis, Sarah E. Pinder, Ian O. Ellis, Barry A. Gusterson, J P Sloane	1998	63

About Sarah E. Pinder

Sarah E. Pinder is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Dermatology and Radiology, Nuclear Medicine and Imaging, having authored 328 papers that have together received 15.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (183 papers), Breast Lesions and Carcinomas (142 papers), HER2/EGFR in Cancer Research (45 papers), AI in cancer detection (33 papers), Global Cancer Incidence and Screening (32 papers), Cancer and Skin Lesions (32 papers), Cancer Genomics and Diagnostics (28 papers) and Breast Implant and Reconstruction (27 papers). The work is most often cited by research in Cancer Research (7.3k citations), Pathology and Forensic Medicine (4.6k citations), Oncology (6.6k citations), Dermatology (1.1k citations) and Radiology, Nuclear Medicine and Imaging (2.0k citations). Sarah E. Pinder has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Ian O. Ellis, J.F.R. Robertson, Carlos Caldas, R.W. Blamey, Arnie Purushotham, Elena Provenzano, C.W. Elston, Claire E. Paish, Dalia M. Abd El‐Rehim and Andrew Evans. Their work appears in journals such as Clinical Radiology, Histopathology, British Journal of Cancer, Journal of Clinical Pathology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact